Cellectis SA (CLLS) – Aktiekurs og nyheder – Google Finans

Finans

StartCLLS • NASDAQ

Cellectis SA

3,47 $

Førmarked:

3,42 $

(1,44 %)-0,050

Lukket: 24. okt., 00.17.30 GMT-4 · USD · NASDAQ · Ansvarsfraskrivelse

CleanSpark Inc

17,67 $

CLSK4,80 %

Clean Energy Fuels Corp

2,86 $

CLNE3,62 %

Nuburu Inc

0,34 $

BURU4,61 %

Sangamo Therapeutics

0,66 $

SGMO0,48 %

Editas Medicine Inc

3,65 $

EDIT2,24 %

CRISPR Therapeutics

67,21 $

CRSP1,04 %

Caribou Biosciences Inc

2,50 $

CRBU1,19 %

Adaptimmune Therapeutics PLC - ADR

0,070 $

ADAP3,45 %

Autolus Therapeutics PLC

1,50 $

AUTL3,23 %

Intellia Therapeutics Inc

25,89 $

NTLA5,33 %

AktieVærdipapir børsnoteret i USA

Seneste lukkekurs

3,59 $

Dagsinterval

3,39 $ - 3,60 $

Årsinterval

1,10 $ - 5,48 $

Markedsværdi

246,78 mio. USD

Gns. volumen

196,18 t

P/E-værdi

-

Udbytteprocent

-

Markedsnyheder

for 2 dage siden

Dow-futures handles i rødt tirsdag: 5 ting at vide, før Wall Street åbner

for 25 minutter siden

DiamondHead (NASDAQ:DHHC) Trading 4.6% Higher - Should You Buy?

for 9 minutter siden

Dow Jones futures gain on confirmation of the Trump-Xi meeting, US CPI awaited

Simply Wall Street

for 1 time siden

Does Dow’s (DOW) Margin Recovery Signal Lasting Operational Strength Amid Persistent Sector Pressures?

for 8 timer siden

Stock futures are little changed ahead of highly awaited inflation data: Live updates

for 1 time siden

Asia to Join Global Equity Rally Ahead of US CPI: Markets Wrap

Om

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia

Administrerende direktør

André Choulika

Grundlagt

1999

Website

Ansatte

219

Søgning

Ryd søgning

Luk søgning

Google-apps

Hovedmenu